Skip to content

Ligand Pharmaceuticals LGND Compensation and benefits

Compensation and benefits at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
Roivant Sciences logo
Roivant SciencesROIV
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
Incyte logo
IncyteINCY
Eli Lilly logo
Eli LillyLLY

Other financials

Income statement

See full
Revenue$51.7M+14.1%
Operating income$17.4M+148%
Net income-$13.3M+68.6%
EPS (diluted)-$0.67+69.7%

Balance sheet

See full
Cash & equivalents$115.1M+140%
Total debt$5.1M+14.2%
Total equity$997.3M+25.4%
Total assets$1.5B+69.2%

Cash flow

See full
Operating cash flow$48.7M+291%
CapEx$228.0K+6.5%
Free cash flow$48.5M+289%

Valuation

See full
Market cap$5.6B+96.7%

Profitability

See full
Gross margin91.9%
Operating margin34.5%+23.0pp
Net margin55.9%+35.7pp
FCF margin44.8%+16.8pp

Returns & leverage

See full
Return on equity17.1%+11.5pp
Debt / equity0.0×
Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ligand Pharmaceuticals's compensation and benefits?
Ligand Pharmaceuticals (LGND) reported compensation and benefits of $3.55M in Q1 2026.
How has Ligand Pharmaceuticals's compensation and benefits changed year-over-year?
Ligand Pharmaceuticals's compensation and benefits increased by 87.9% year-over-year, from $1.89M to $3.55M.
What is the long-term trend for Ligand Pharmaceuticals's compensation and benefits?
Over 5 years (2020 to 2025), Ligand Pharmaceuticals's compensation and benefits has grown at a -6.2% compound annual growth rate (CAGR), from $8.81M to $6.39M.